Stockscreener 앱 받기
0.00
100.00%
-2.38
전일 마감가:
$2.38
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$114.97M
수익:
-
순이익/손실:
$-97.22M
주가수익비율:
0.00
EPS:
-1.38
순현금흐름:
$-82.44M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$4.98
카사바 Stock (SAVA) Company Profile
명칭
Cassava Sciences Inc
전화
512-501-2444
주소
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Compare SAVA vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
0.00 | 114.97M | 0 | -97.22M | -82.44M | -1.38 |
VRTX
Vertex Pharmaceuticals Inc
|
447.54 | 113.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.78 | 65.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
835.99 | 52.14B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.98 | 40.73B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.48 | 32.87B | 742.00K | -1.37B | -1.07B | -7.0731 |
카사바 Stock (SAVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-27 | 개시 | B. Riley Securities | Buy |
| 2021-02-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-01-10 | 재확인 | Maxim Group | Buy |
모두보기
카사바 주식(SAVA)의 최신 뉴스
Cassava Sciences (FLNA) Insider Trading Activity 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) Institutional Ownership 2026 $FLNA - MarketBeat
Top Cassava Sciences (FLNA) Competitors 2026 - MarketBeat
Cassava Sciences stock (US14428V1035): pressure grows as short interest stays elevated after ticker - AD HOC NEWS
Cassava Sciences (FLNA) Short Interest & Short Float | Updated May 2026 $FLNA - MarketBeat
Cassava Sciences stock (US14428V1035): Clinical progress in Alzheimer's treatments - AD HOC NEWS
TradingKey - TradingKey
Cassava Sciences (NASDAQ:FLNA) Posts Earnings Results - MarketBeat
Cassava Sciences stock (US14428V1035): Alzheimer drug candidate in focus after latest data update - AD HOC NEWS
FLNA Stock Price and Chart — NASDAQ:FLNA - TradingView
Cassava Sciences | 8-K: Current report - Moomoo
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - Yahoo Finance
FLNA Stock Price, Quote & Chart | FILANA THERAPEUTICS INC (NASDAQ:FLNA) - ChartMill
Cassava Sciences says DOJ has closed probe into allegations around its Alzheimer’s program - MSN
Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan
Cassava Sciences (FLNA) Financials 2026Income Statement and Balance Sheet $FLNA - MarketBeat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - ACCESS Newswire
Cassava Sciences (FLNA) Stock Chart and Price History 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Cassava Sciences (FLNA) Stock Trends and Sentiment 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) Earnings Date and Reports 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) Options Chain & Prices 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) Stock Forecast and Price Target 2026 $FLNA - MarketBeat
Cassava Sciences (FLNA) Stock Price, News & Analysis $FLNA - MarketBeat
Cassava Sciences (NASDAQ:SAVA) Stock Price Down 0.6%Should You Sell? - MarketBeat
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
FLNA Stock Price, News & Analysis - Stock Titan
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data - GlobeNewswire
Death Cross: What are the future prospects of Cassava Sciences Inc Equity WarrantPortfolio Gains Summary & Verified Chart Pattern Trade Signals - baoquankhu1.vn
FLNA|Cassava Sciences Ord Shs|Price:1.440|Chg%:0.06 - TradingKey
FLNA|Cassava Sciences Ord Shs|Price:1.440|Chg%:-0.12 - TradingKey
If You Invested $1,000 in Cassava Sciences (SAVA) - Stock Titan
Trend Report: What is the dividend yield of Cassava Sciences Inc Equity Warrant2026 Geopolitical Influence & Entry and Exit Point Strategies - baoquankhu1.vn
Aug Chart Watch: Is Cassava Sciences Inc Equity Warrant trading at a discountWeekly Market Outlook & High Accuracy Swing Trade Signals - baoquankhu1.vn
Market Leaders: Can Cassava Sciences Inc Equity Warrant maintain its current growth rate2026 Levels & Low Risk Investment Opportunities - baoquankhu1.vn
Aug Update: Is Cassava Sciences Inc Equity Warrant subject to activist investor interestWatch List & Consistent Return Investment Signals - baoquankhu1.vn
RSI Check: What is the dividend yield of Cassava Sciences IncPortfolio Performance Report & High Conviction Buy Zone Alerts - baoquankhu1.vn
SEC Moves To Set Up $40M Investor Fund In Cassava Case - Law360
Cassava Sciences Stock Rises 1.8% - nationaltoday.com
Cassava Sciences (NASDAQ:SAVA) Stock Price Up 1.8%Here's What Happened - MarketBeat
RSI Check: Is Cassava Sciences Inc backed by strong institutional buying2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn
Dow Update: What is the dividend yield of Cassava Sciences Inc Equity WarrantInsider Selling & Proven Capital Preservation Tips - baoquankhu1.vn
Cassava Sciences, Inc. (FLNA) - Minichart
Cassava Sciences Inc Share PriceShare CFDs - FOREX.com
Energy Moves: What is Cassava Sciences Inc Equity Warrants book value per share - baoquankhu1.vn
SAVA PE Ratio & Valuation, Is SAVA Overvalued - Intellectia AI
ETF Watch: What are the future prospects of Cassava Sciences Inc Equity WarrantPortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urg - GuruFocus
Cassava Sciences, Inc. Common Stock (FLNA) Competitors - Meyka
카사바 (SAVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
카사바 주식 (SAVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Barry Richard | President & CEO |
Nov 20 '25 |
Buy |
2.76 |
150,000 |
414,000 |
938,060 |
| Barry Richard | President & CEO |
Nov 19 '25 |
Buy |
2.75 |
73,385 |
201,809 |
788,060 |
| Cook Robert Christopher | Chief Operating & Legal Office |
Sep 30 '25 |
Buy |
2.91 |
13,725 |
39,940 |
13,725 |
| Barry Richard | President & CEO |
Sep 22 '25 |
Buy |
2.28 |
7,172 |
16,352 |
714,675 |
| Barry Richard | President & CEO |
Sep 18 '25 |
Buy |
2.24 |
190,633 |
426,424 |
660,195 |
| Barry Richard | President & CEO |
Sep 19 '25 |
Buy |
2.29 |
47,308 |
108,319 |
707,503 |
0.37%
1.35%
자본화:
|
볼륨(24시간):